Project Grant HT94252510948
Award Date 9/1/25
Completion Date 8/31/28
Dollars Obligated $549K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Talleyville, DE 19803, USA
Similar Awards
- The Nemours Foundation was awarded a $497,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research into novel immunotherapy options for pediatric acute myeloid leukemia from September 15, 2022 to September 14, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of improving health care for...
- This $713,818 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by the Research Institute at Nationwide Children's Hospital in Columbus, Ohio to characterize novel patient-specific modeling systems for NF2 disease research and therapeutic testing. The project will be conducted from September 1, 2024 through August 31, 2027. The Research Institute has extensive experience delivering federal research...
- The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $858,033 Project Grant to the Children's Hospital Medical Center in Cincinnati, Ohio. The grant, titled "TARGETING SCHWANN CELL-IMMUNE INTERACTIONS IN NEUROFIBROMATOSIS TYPE 1", will fund research focused on improving treatment approaches for neurofibromatosis type 1, a genetic disorder that causes tumor growth in the nervous system. The grant award period runs from...
- The Defense Health Agency awarded a $697,766 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Murdoch Children's Research Institute in Australia. The grant, awarded on July 15, 2024, will fund a 3-year research project titled "BRAIN CHARTS IN CHILDREN AND ADOLESCENTS WITH NEUROFIBROMATOSIS TYPE 1". The project aims to conduct biomedical research to better understand and characterize brain development in children and adolescents with...
- The Department of the Army Medical Command awarded $1.393 million to the Children's Research Institute under the Military Medical Research and Development federal grant program (CFDA 12.420) to support an early-phase study evaluating MEK and MDM2 inhibition in patients with neurofibromatosis type 1 and premalignant and malignant peripheral nerve sheath tumors. The Children's Research Institute will conduct the clinical trial through September 2026 to investigate medical solutions for...
- The Project Grant award of $624,000 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program to the Research Institute at Nationwide Children's Hospital. The funding supports a project titled "SPLICING UP PD-L1 FOR IMMUNOTHERAPY ENHANCEMENT IN PEDIATRIC NEURONAL TUMORS" over a two-year period from September 30, 2023 to September 29, 2025. The goal is to conduct research to advance immunotherapy approaches...
- The Project Grant award of $649,000.00 from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) to Rutgers, The State University of New Jersey will support research to characterize the oncogenic transcriptional activation during the malignant transformation of NF1 nerve sheath tumors. The award period runs from August 1, 2025 to July 31, 2028. This research aims to advance the scientific understanding of the genetic and molecular mechanisms underlying...
- This federal Project Grant award for $734,542 was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The grant supports research to develop novel biomarkers of plexiform neurofibroma tumor burden in neurofibromatosis type 1 (NF1) patients. Key products and services to be delivered include: Analytical validation studies of a candidate glucosylceramide (GC) and...
- The Department of Defense, through its Military Medical Research and Development program (CFDA 12.420), awarded a $624,000 project grant to the Research Institute at Nationwide Children's Hospital in Columbus, Ohio. The 2-year grant, which began on September 1, 2025, will support comprehensive in vivo phenotyping research on fusion-driven pediatric rhabdomyosarcomas. The Research Institute, a leading pediatric research organization, will leverage its expertise in advanced biomedical research and...
- This federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $1,366,365.00 to The Children's Hospital of Philadelphia (CHOP) to conduct a research study titled "BRAIN CHARTS IN CHILDREN AND ADOLESCENTS WITH NEUROFIBROMATOSIS TYPE 1". The study aims to advance healthcare for children by improving the understanding of brain development in those with neurofibromatosis type 1, a genetic disorder that...